FTO is the first m6A demethylase discovered to promote NSCLC cell growth by demethylating USP7 mRNA or MZF1 mRNA transcripts and increasing their stability and transcriptional levels [108,109]. Here, FTO is linked to non-small cell lung carcinoma.